-
1
-
-
0035188740
-
Behaviour of Crohn's disease according to the Vienna classification: Changing pattern over the course of the disease
-
Louis E, Collard A, Oger AF, Degroote E, Aboul Nasr El Yafi FA, Belaiche J. Behaviour of Crohn's disease according to the Vienna classification: changing pattern over the course of the disease. Gut 2001; 49: 777-782
-
(2001)
Gut
, vol.49
, pp. 777-782
-
-
Louis, E.1
Collard, A.2
Oger, A.F.3
Degroote, E.4
El Aboul Nasr, Y.F.A.5
Belaiche, J.6
-
2
-
-
0036061640
-
Long-term evolution of disease behavior of Crohn's disease
-
Cosnes J, Cattan S, Blain A, Beaugerie L, Carbonnel F, Parc R, Gendre JP. Long-term evolution of disease behavior of Crohn's disease. Inflamm Bowel Dis 2002; 8: 244-250
-
(2002)
Inflamm Bowel Dis
, vol.8
, pp. 244-250
-
-
Cosnes, J.1
Cattan, S.2
Blain, A.3
Beaugerie, L.4
Carbonnel, F.5
Parc, R.6
Gendre, J.P.7
-
3
-
-
0018903830
-
Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease
-
Hellers G, Bergstrand O, Ewerth S, Holmström B. Occurrence and outcome after primary treatment of anal fistulae in Crohn's disease. Gut 1980; 21: 525-527
-
(1980)
Gut
, vol.21
, pp. 525-527
-
-
Hellers, G.1
Bergstrand, O.2
Ewerth, S.3
Holmström, B.4
-
4
-
-
0018308190
-
Clinical features and natural history of Crohn's disease
-
Mekhjian HS, Switz DM, Melnyk CS, Rankin GB, Brooks RK. Clinical features and natural history of Crohn's disease. Gastroenterology 1979; 77: 898-906
-
(1979)
Gastroenterology
, vol.77
, pp. 898-906
-
-
Mekhjian, H.S.1
Switz, D.M.2
Melnyk, C.S.3
Rankin, G.B.4
Brooks, R.K.5
-
5
-
-
79955844087
-
Development of the Crohn's disease digestive damage score, the Lémann score
-
Pariente B, Cosnes J, Danese S, Sandborn WJ, Lewin M, Fletcher JG, Chowers Y, D'Haens G, Feagan BG, Hibi T, Hommes DW, Irvine EJ, Kamm MA, Loftus EV, Louis E, Michetti P, Munkholm P, Oresland T, Panés J, Peyrin-Biroulet L, Reinisch W, Sands BE, Schoelmerich J, Schreiber S, Tilg H, Travis S, van Assche G, Vecchi M, Mary JY, Colombel JF, Lémann M. Development of the Crohn's disease digestive damage score, the Lémann score. Inflamm Bowel Dis 2011; 17: 1415-1422
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 1415-1422
-
-
Pariente, B.1
Cosnes, J.2
Danese, S.3
Sandborn, W.J.4
Lewin, M.5
Fletcher, J.G.6
Chowers, Y.7
D'Haens, G.8
Feagan, B.G.9
Hibi, T.10
Hommes, D.W.11
Irvine, E.J.12
Kamm, M.A.13
Loftus, E.V.14
Louis, E.15
Michetti, P.16
Munkholm, P.17
Oresland, T.18
Panés, J.19
Peyrin-Biroulet, L.20
Reinisch, W.21
Sands, B.E.22
Schoelmerich, J.23
Schreiber, S.24
Tilg, H.25
Travis, S.26
van Assche, G.27
Vecchi, M.28
Mary, J.Y.29
Colombel, J.F.30
Lémann, M.31
more..
-
6
-
-
0035080617
-
The risk of colorectal cancer in ulcerative colitis: A meta-analysis
-
Eaden JA, Abrams KR, Mayberry JF. The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut 2001; 48: 526-535
-
(2001)
Gut
, vol.48
, pp. 526-535
-
-
Eaden, J.A.1
Abrams, K.R.2
Mayberry, J.F.3
-
7
-
-
55249091834
-
Current directions in IBD therapy: What goals are feasible with biological modifiers?
-
Sandborn WJ. Current directions in IBD therapy: what goals are feasible with biological modifiers? Gastroenterology 2008; 135: 1442-1447
-
(2008)
Gastroenterology
, vol.135
, pp. 1442-1447
-
-
Sandborn, W.J.1
-
9
-
-
0021266269
-
Natural history of recurrent Crohn' s disease at the ileocolonic anastomosis after curative surgery
-
Rutgeerts P, Geboes K, Vantrappen G, Kerremans R, Coenegrachts JL, Coremans G. Natural history of recurrent Crohn' s disease at the ileocolonic anastomosis after curative surgery. Gut 1984; 25: 665-672
-
(1984)
Gut
, vol.25
, pp. 665-672
-
-
Rutgeerts, P.1
Geboes, K.2
Vantrappen, G.3
Kerremans, R.4
Coenegrachts, J.L.5
Coremans, G.6
-
10
-
-
83955162272
-
Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped
-
quiz e31
-
Louis E, Mary JY, Vernier-Massouille G, Grimaud JC, Bouhnik Y, Laharie D, Dupas JL, Pillant H, Picon L, Veyrac M, Flamant M, Savoye G, Jian R, Devos M, Porcher R, Paintaud G, Piver E, Colombel JF, Lemann M. Maintenance of remission among patients with Crohn's disease on antimetabolite therapy after infliximab therapy is stopped. Gastroenterology 2012; 142: 63-70. e5; quiz e31
-
(2012)
Gastroenterology
, vol.142
-
-
Louis, E.1
Mary, J.Y.2
Vernier-Massouille, G.3
Grimaud, J.C.4
Bouhnik, Y.5
Laharie, D.6
Dupas, J.L.7
Pillant, H.8
Picon, L.9
Veyrac, M.10
Flamant, M.11
Savoye, G.12
Jian, R.13
Devos, M.14
Porcher, R.15
Paintaud, G.16
Piver, E.17
Colombel, J.F.18
Lemann, M.19
-
11
-
-
0028881322
-
An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease
-
Sandborn WJ, Van O EC, Zins BJ, Tremaine WJ, Mays DC, Lipsky JJ. An intravenous loading dose of azathioprine decreases the time to response in patients with Crohn's disease. Gastroenterology 1995; 109: 1808-1817
-
(1995)
Gastroenterology
, vol.109
, pp. 1808-1817
-
-
Sandborn, W.J.1
van O, E.C.2
Zins, B.J.3
Tremaine, W.J.4
Mays, D.C.5
Lipsky, J.J.6
-
12
-
-
0032723990
-
Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine
-
D'Haens G, Geboes K, Rutgeerts P. Endoscopic and histologic healing of Crohn's (ileo-) colitis with azathioprine. Gastrointest Endosc 1999; 50: 667-671
-
(1999)
Gastrointest Endosc
, vol.50
, pp. 667-671
-
-
D'Haens, G.1
Geboes, K.2
Rutgeerts, P.3
-
13
-
-
77950988234
-
Infliximab, azathioprine, or combination therapy for Crohn's disease
-
Colombel JF, Sandborn WJ, Reinisch W, Mantzaris GJ, Kornbluth A, Rachmilewitz D, Lichtiger S, D'Haens G, Diamond RH, Broussard DL, Tang KL, van der Woude CJ, Rutgeerts P. Infliximab, azathioprine, or combination therapy for Crohn's disease. N Engl J Med 2010; 362: 1383-1395
-
(2010)
N Engl J Med
, vol.362
, pp. 1383-1395
-
-
Colombel, J.F.1
Sandborn, W.J.2
Reinisch, W.3
Mantzaris, G.J.4
Kornbluth, A.5
Rachmilewitz, D.6
Lichtiger, S.7
D'Haens, G.8
Diamond, R.H.9
Broussard, D.L.10
Tang, K.L.11
van der Woude, C.J.12
Rutgeerts, P.13
-
14
-
-
0024517127
-
Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease
-
Kozarek RA, Patterson DJ, Gelfand MD, Botoman VA, Ball TJ, Wilske KR. Methotrexate induces clinical and histologic remission in patients with refractory inflammatory bowel disease. Ann Intern Med 1989; 110: 353-356
-
(1989)
Ann Intern Med
, vol.110
, pp. 353-356
-
-
Kozarek, R.A.1
Patterson, D.J.2
Gelfand, M.D.3
Botoman, V.A.4
Ball, T.J.5
Wilske, K.R.6
-
15
-
-
79951674459
-
Mucosal healing with methotrexate in Crohn's disease: A prospective comparative study with azathioprine and infliximab
-
Laharie D, Reffet A, Belleannée G, Chabrun E, Subtil C, Razaire S, Capdepont M, de Lédinghen V. Mucosal healing with methotrexate in Crohn's disease: a prospective comparative study with azathioprine and infliximab. Aliment Pharmacol Ther 2011; 33: 714-721
-
(2011)
Aliment Pharmacol Ther
, vol.33
, pp. 714-721
-
-
Laharie, D.1
Reffet, A.2
Belleannée, G.3
Chabrun, E.4
Subtil, C.5
Razaire, S.6
Capdepont, M.7
de Lédinghen, V.8
-
16
-
-
0032913394
-
Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial
-
D'haens G, Van Deventer S, Van Hogezand R, Chalmers D, Kothe C, Baert F, Braakman T, Schaible T, Geboes K, Rutgeerts P. Endoscopic and histological healing with infliximab anti-tumor necrosis factor antibodies in Crohn's disease: A European multicenter trial. Gastroenterology 1999; 116: 1029-1034
-
(1999)
Gastroenterology
, vol.116
, pp. 1029-1034
-
-
D'haens, G.1
van Deventer, S.2
van Hogezand, R.3
Chalmers, D.4
Kothe, C.5
Baert, F.6
Braakman, T.7
Schaible, T.8
Geboes, K.9
Rutgeerts, P.10
-
17
-
-
70350172248
-
Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease
-
Schnitzler F, Fidder H, Ferrante M, Noman M, Arijs I, Van Assche G, Hoffman I, Van Steen K, Vermeire S, Rutgeerts P. Mucosal healing predicts long-term outcome of maintenance therapy with infliximab in Crohn's disease. Inflamm Bowel Dis 2009; 15: 1295-1301
-
(2009)
Inflamm Bowel Dis
, vol.15
, pp. 1295-1301
-
-
Schnitzler, F.1
Fidder, H.2
Ferrante, M.3
Noman, M.4
Arijs, I.5
van Assche, G.6
Hoffman, I.7
van Steen, K.8
Vermeire, S.9
Rutgeerts, P.10
-
18
-
-
75449114677
-
Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease
-
quiz 10-11
-
Baert F, Moortgat L, Van Assche G, Caenepeel P, Vergauwe P, De Vos M, Stokkers P, Hommes D, Rutgeerts P, Vermeire S, D'Haens G. Mucosal healing predicts sustained clinical remission in patients with early-stage Crohn's disease. Gastroenterology 2010; 138: 463-468; quiz 10-11
-
(2010)
Gastroenterology
, vol.138
, pp. 463-468
-
-
Baert, F.1
Moortgat, L.2
van Assche, G.3
Caenepeel, P.4
Vergauwe, P.5
de Vos, M.6
Stokkers, P.7
Hommes, D.8
Rutgeerts, P.9
Vermeire, S.10
D'Haens, G.11
-
19
-
-
84856163835
-
Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis
-
Sandborn WJ, van Assche G, Reinisch W, Colombel JF, D' Haens G, Wolf DC, Kron M, Tighe MB, Lazar A, Thakkar RB. Adalimumab induces and maintains clinical remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2012; 142: 257-265. e1-3
-
(2012)
Gastroenterology
, vol.142
-
-
Sandborn, W.J.1
van Assche, G.2
Reinisch, W.3
Colombel, J.F.4
D' Haens, G.5
Wolf, D.C.6
Kron, M.7
Tighe, M.B.8
Lazar, A.9
Thakkar, R.B.10
-
20
-
-
31344455134
-
Top-down versus step-up approaches to chronic inflammatory bowel disease: Presumed innocent or presumed guilty
-
Hanauer SB. Top-down versus step-up approaches to chronic inflammatory bowel disease: presumed innocent or presumed guilty. Nat Clin Pract Gastroenterol Hepatol 2005; 2: 493
-
(2005)
Nat Clin Pract Gastroenterol Hepatol
, vol.2
, pp. 493
-
-
Hanauer, S.B.1
-
21
-
-
0029875942
-
Changes in extent of ulcerative colitis: A study on the course and prognostic factors
-
Langholz E, Munkholm P, Davidsen M, Nielsen OH, Binder V. Changes in extent of ulcerative colitis: a study on the course and prognostic factors. Scand J Gastroenterol 1996; 31: 260-266
-
(1996)
Scand J Gastroenterol
, vol.31
, pp. 260-266
-
-
Langholz, E.1
Munkholm, P.2
Davidsen, M.3
Nielsen, O.H.4
Binder, V.5
-
22
-
-
33847197932
-
Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years
-
Hoie O, Wolters FL, Riis L, Bernklev T, Aamodt G, Clofent J, Tsianos E, Beltrami M, Odes S, Munkholm P, Vatn M, Stockbrügger RW, Moum B. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007; 132: 507-515
-
(2007)
Gastroenterology
, vol.132
, pp. 507-515
-
-
Hoie, O.1
Wolters, F.L.2
Riis, L.3
Bernklev, T.4
Aamodt, G.5
Clofent, J.6
Tsianos, E.7
Beltrami, M.8
Odes, S.9
Munkholm, P.10
Vatn, M.11
Stockbrügger, R.W.12
Moum, B.13
-
23
-
-
12344291265
-
Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery
-
Cosnes J, Nion-Larmurier I, Beaugerie L, Afchain P, Tiret E, Gendre JP. Impact of the increasing use of immunosuppressants in Crohn's disease on the need for intestinal surgery. Gut 2005; 54: 237-241
-
(2005)
Gut
, vol.54
, pp. 237-241
-
-
Cosnes, J.1
Nion-Larmurier, I.2
Beaugerie, L.3
Afchain, P.4
Tiret, E.5
Gendre, J.P.6
-
24
-
-
77955096659
-
Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): A study of changes in medical treatment and surgical resection rates
-
Ramadas AV, Gunesh S, Thomas GA, Williams GT, Hawthorne AB. Natural history of Crohn's disease in a population-based cohort from Cardiff (1986-2003): a study of changes in medical treatment and surgical resection rates. Gut 2010; 59: 1200-1206
-
(2010)
Gut
, vol.59
, pp. 1200-1206
-
-
Ramadas, A.V.1
Gunesh, S.2
Thomas, G.A.3
Williams, G.T.4
Hawthorne, A.B.5
-
25
-
-
79958228566
-
Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease
-
Peyrin-Biroulet L, Oussalah A, Williet N, Pillot C, Bresler L, Bigard MA. Impact of azathioprine and tumour necrosis factor antagonists on the need for surgery in newly diagnosed Crohn's disease. Gut 2011; 60: 930-936
-
(2011)
Gut
, vol.60
, pp. 930-936
-
-
Peyrin-Biroulet, L.1
Oussalah, A.2
Williet, N.3
Pillot, C.4
Bresler, L.5
Bigard, M.A.6
-
26
-
-
29244457275
-
Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis
-
Ardizzone S, Maconi G, Russo A, Imbesi V, Colombo E, Bianchi Porro G. Randomised controlled trial of azathioprine and 5-aminosalicylic acid for treatment of steroid dependent ulcerative colitis. Gut 2006; 55: 47-53
-
(2006)
Gut
, vol.55
, pp. 47-53
-
-
Ardizzone, S.1
McOni, G.2
Russo, A.3
Imbesi, V.4
Colombo, E.5
Bianchi Porro, G.6
-
27
-
-
0037018761
-
Maintenance infliximab for Crohn's disease: The ACCENT I randomised trial
-
Hanauer SB, Feagan BG, Lichtenstein GR, Mayer LF, Schreiber S, Colombel JF, Rachmilewitz D, Wolf DC, Olson A, Bao W, Rutgeerts P. Maintenance infliximab for Crohn's disease: the ACCENT I randomised trial. Lancet 2002; 359: 1541-1549
-
(2002)
Lancet
, vol.359
, pp. 1541-1549
-
-
Hanauer, S.B.1
Feagan, B.G.2
Lichtenstein, G.R.3
Mayer, L.F.4
Schreiber, S.5
Colombel, J.F.6
Rachmilewitz, D.7
Wolf, D.C.8
Olson, A.9
Bao, W.10
Rutgeerts, P.11
-
28
-
-
5044235159
-
Long-term treatment of rectovaginal fistulas in Crohn's disease: Response to infliximab in the ACCENT II Study
-
Sands BE, Blank MA, Patel K, van Deventer SJ. Long-term treatment of rectovaginal fistulas in Crohn's disease: response to infliximab in the ACCENT II Study. Clin Gastroenterol Hepatol 2004; 2: 912-920
-
(2004)
Clin Gastroenterol Hepatol
, vol.2
, pp. 912-920
-
-
Sands, B.E.1
Blank, M.A.2
Patel, K.3
van Deventer, S.J.4
-
29
-
-
34547503869
-
Mucosal healing in inflammatory bowel disease: Results from a Norwegian population-based cohort
-
Frøslie KF, Jahnsen J, Moum BA, Vatn MH. Mucosal healing in inflammatory bowel disease: results from a Norwegian population-based cohort. Gastroenterology 2007; 133: 412-422
-
(2007)
Gastroenterology
, vol.133
, pp. 412-422
-
-
Frøslie, K.F.1
Jahnsen, J.2
Moum, B.A.3
Vatn, M.H.4
-
30
-
-
77955170773
-
Trends in surgery for Crohn's disease in the era of infliximab
-
Jones DW, Finlayson SR. Trends in surgery for Crohn's disease in the era of infliximab. Ann Surg 2010; 252: 307-312
-
(2010)
Ann Surg
, vol.252
, pp. 307-312
-
-
Jones, D.W.1
Finlayson, S.R.2
-
31
-
-
55449098725
-
Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: Results from the CHARM study
-
Feagan BG, Panaccione R, Sandborn WJ, D'Haens GR, Schreiber S, Rutgeerts PJ, Loftus EV, Lomax KG, Yu AP, Wu EQ, Chao J, Mulani P. Effects of adalimumab therapy on incidence of hospitalization and surgery in Crohn's disease: results from the CHARM study. Gastroenterology 2008; 135: 1493-1499
-
(2008)
Gastroenterology
, vol.135
, pp. 1493-1499
-
-
Feagan, B.G.1
Panaccione, R.2
Sandborn, W.J.3
D'Haens, G.R.4
Schreiber, S.5
Rutgeerts, P.J.6
Loftus, E.V.7
Lomax, K.G.8
Yu, A.P.9
Wu, E.Q.10
Chao, J.11
Mulani, P.12
-
32
-
-
77952748486
-
Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease
-
Panaccione R, Colombel JF, Sandborn WJ, Rutgeerts P, D' Haens GR, Robinson AM, Chao J, Mulani PM, Pollack PF. Adalimumab sustains clinical remission and overall clinical benefit after 2 years of therapy for Crohn's disease. Aliment Pharmacol Ther 2010; 31: 1296-1309
-
(2010)
Aliment Pharmacol Ther
, vol.31
, pp. 1296-1309
-
-
Panaccione, R.1
Colombel, J.F.2
Sandborn, W.J.3
Rutgeerts, P.4
D' Haens, G.R.5
Robinson, A.M.6
Chao, J.7
Mulani, P.M.8
Pollack, P.F.9
-
33
-
-
70349418632
-
Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab
-
quiz 1520
-
Sandborn WJ, Rutgeerts P, Feagan BG, Reinisch W, Olson A, Johanns J, Lu J, Horgan K, Rachmilewitz D, Hanauer SB, Lichtenstein GR, de Villiers WJ, Present D, Sands BE, Colombel JF. Colectomy rate comparison after treatment of ulcerative colitis with placebo or infliximab. Gastroenterology 2009; 137: 1250-1260; quiz 1520
-
(2009)
Gastroenterology
, vol.137
, pp. 1250-1260
-
-
Sandborn, W.J.1
Rutgeerts, P.2
Feagan, B.G.3
Reinisch, W.4
Olson, A.5
Johanns, J.6
Lu, J.7
Horgan, K.8
Rachmilewitz, D.9
Hanauer, S.B.10
Lichtenstein, G.R.11
de Villiers, W.J.12
Present, D.13
Sands, B.E.14
Colombel, J.F.15
-
34
-
-
80053130407
-
Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis
-
Colombel JF, Rutgeerts P, Reinisch W, Esser D, Wang Y, Lang Y, Marano CW, Strauss R, Oddens BJ, Feagan BG, Hanauer SB, Lichtenstein GR, Present D, Sands BE, Sandborn WJ. Early mucosal healing with infliximab is associated with improved long-term clinical outcomes in ulcerative colitis. Gastroenterology 2011; 141: 1194-1201
-
(2011)
Gastroenterology
, vol.141
, pp. 1194-1201
-
-
Colombel, J.F.1
Rutgeerts, P.2
Reinisch, W.3
Esser, D.4
Wang, Y.5
Lang, Y.6
Marano, C.W.7
Strauss, R.8
Oddens, B.J.9
Feagan, B.G.10
Hanauer, S.B.11
Lichtenstein, G.R.12
Present, D.13
Sands, B.E.14
Sandborn, W.J.15
-
35
-
-
78650147806
-
Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: Results from a prospective study
-
Roumeguère P, Bouchard D, Pigot F, Castinel A, Juguet F, Gaye D, Capdepont M, Zerbib F, Laharie D. Combined approach with infliximab, surgery, and methotrexate in severe fistulizing anoperineal Crohn's disease: results from a prospective study. Inflamm Bowel Dis 2011; 17: 69-76
-
(2011)
Inflamm Bowel Dis
, vol.17
, pp. 69-76
-
-
Roumeguère, P.1
Bouchard, D.2
Pigot, F.3
Castinel, A.4
Juguet, F.5
Gaye, D.6
Capdepont, M.7
Zerbib, F.8
Laharie, D.9
-
36
-
-
83555163744
-
Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: Results from CARE
-
Löfberg R, Louis EV, Reinisch W, Robinson AM, Kron M, Camez A, Pollack PF. Adalimumab produces clinical remission and reduces extraintestinal manifestations in Crohn's disease: results from CARE. Inflamm Bowel Dis 2012; 18: 1-9
-
(2012)
Inflamm Bowel Dis
, vol.18
, pp. 1-9
-
-
Löfberg, R.1
Louis, E.V.2
Reinisch, W.3
Robinson, A.M.4
Kron, M.5
Camez, A.6
Pollack, P.F.7
-
38
-
-
71949124966
-
Further studies on the frequency of colorectal cancer in Crohn's colitis: An 11-year survey in the Northwest Stockholm County
-
Rubio CA, Kapraali M, Befrits R. Further studies on the frequency of colorectal cancer in Crohn's colitis: an 11-year survey in the Northwest Stockholm County. Anticancer Res 2009; 29: 4291-4295
-
(2009)
Anticancer Res
, vol.29
, pp. 4291-4295
-
-
Rubio, C.A.1
Kapraali, M.2
Befrits, R.3
-
39
-
-
0025167285
-
Increased risk of large-bowel cancer in Crohn's disease with colonic involvement
-
Ekbom A, Helmick C, Zack M, Adami HO. Increased risk of large-bowel cancer in Crohn's disease with colonic involvement. Lancet 1990; 336: 357-359
-
(1990)
Lancet
, vol.336
, pp. 357-359
-
-
Ekbom, A.1
Helmick, C.2
Zack, M.3
Adami, H.O.4
-
40
-
-
78149284063
-
Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis
-
Bergeron V, Vienne A, Sokol H, Seksik P, Nion-Larmurier I, Ruskone-Fourmestraux A, Svrcek M, Beaugerie L, Cosnes J. Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis. Am J Gastroenterol 2010; 105: 2405-2411
-
(2010)
Am J Gastroenterol
, vol.105
, pp. 2405-2411
-
-
Bergeron, V.1
Vienne, A.2
Sokol, H.3
Seksik, P.4
Nion-Larmurier, I.5
Ruskone-Fourmestraux, A.6
Svrcek, M.7
Beaugerie, L.8
Cosnes, J.9
-
41
-
-
10744221150
-
Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis
-
Rutter M, Saunders B, Wilkinson K, Rumbles S, Schofield G, Kamm M, Williams C, Price A, Talbot I, Forbes A. Severity of inflammation is a risk factor for colorectal neoplasia in ulcerative colitis. Gastroenterology 2004; 126: 451-459
-
(2004)
Gastroenterology
, vol.126
, pp. 451-459
-
-
Rutter, M.1
Saunders, B.2
Wilkinson, K.3
Rumbles, S.4
Schofield, G.5
Kamm, M.6
Williams, C.7
Price, A.8
Talbot, I.9
Forbes, A.10
-
42
-
-
1642492952
-
Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis
-
Rutter MD, Saunders BP, Schofield G, Forbes A, Price AB, Talbot IC. Pancolonic indigo carmine dye spraying for the detection of dysplasia in ulcerative colitis. Gut 2004; 53: 256-260
-
(2004)
Gut
, vol.53
, pp. 256-260
-
-
Rutter, M.D.1
Saunders, B.P.2
Schofield, G.3
Forbes, A.4
Price, A.B.5
Talbot, I.C.6
-
43
-
-
34848893583
-
Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: A cohort study
-
quiz 1340-1341
-
Gupta RB, Harpaz N, Itzkowitz S, Hossain S, Matula S, Kornbluth A, Bodian C, Ullman T. Histologic inflammation is a risk factor for progression to colorectal neoplasia in ulcerative colitis: a cohort study. Gastroenterology 2007; 133: 1099-1105; quiz 1340-1341
-
(2007)
Gastroenterology
, vol.133
, pp. 1099-1105
-
-
Gupta, R.B.1
Harpaz, N.2
Itzkowitz, S.3
Hossain, S.4
Matula, S.5
Kornbluth, A.6
Bodian, C.7
Ullman, T.8
-
44
-
-
50649115967
-
Risk factors associated with small bowel adenocarcinoma in Crohn's disease: A case-control study
-
Piton G, Cosnes J, Monnet E, Beaugerie L, Seksik P, Savoye G, Cadiot G, Flourie B, Capelle P, Marteau P, Lemann M, Colombel JF, Khouri E, Bonaz B, Carbonnel F. Risk factors associated with small bowel adenocarcinoma in Crohn's disease: a case-control study. Am J Gastroenterol 2008; 103: 1730-1736
-
(2008)
Am J Gastroenterol
, vol.103
, pp. 1730-1736
-
-
Piton, G.1
Cosnes, J.2
Monnet, E.3
Beaugerie, L.4
Seksik, P.5
Savoye, G.6
Cadiot, G.7
Flourie, B.8
Capelle, P.9
Marteau, P.10
Lemann, M.11
Colombel, J.F.12
Khouri, E.13
Bonaz, B.14
Carbonnel, F.15
-
45
-
-
79959377068
-
Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: A clinical practice survey nested in the CESAME cohort
-
Vienne A, Simon T, Cosnes J, Baudry C, Bouhnik Y, Soulé JC, Chaussade S, Marteau P, Jian R, Delchier JC, Coffin B, Admane H, Carrat F, Drouet E, Beaugerie L. Low prevalence of colonoscopic surveillance of inflammatory bowel disease patients with longstanding extensive colitis: a clinical practice survey nested in the CESAME cohort. Aliment Pharmacol Ther 2011; 34: 188-195
-
(2011)
Aliment Pharmacol Ther
, vol.34
, pp. 188-195
-
-
Vienne, A.1
Simon, T.2
Cosnes, J.3
Baudry, C.4
Bouhnik, Y.5
Soulé, J.C.6
Chaussade, S.7
Marteau, P.8
Jian, R.9
Delchier, J.C.10
Coffin, B.11
Admane, H.12
Carrat, F.13
Drouet, E.14
Beaugerie, L.15
|